- Advanced search
- Immuno Portal
- Malaria Portal
Ligand id: 4594
View more information in the IUPHAR Pharmacology Education Project: dapagliflozin
Molecular properties generated using the CDK
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
1. Kang SY, Song KS, Lee J, Lee SH, Lee J. (2010)
Synthesis of pyridazine and thiazole analogs as SGLT2 inhibitors.
Bioorg. Med. Chem., 18 (16): 6069-79. [PMID:20637636]
2. Li AR, Zhang J, Greenberg J, Lee T, Liu J. (2011)
Discovery of non-glucoside SGLT2 inhibitors.
Bioorg. Med. Chem. Lett., 21 (8): 2472-5. [PMID:21398124]
3. McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J et al.. (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N. Engl. J. Med., 381 (21): 1995-2008. [PMID:31535829]